The Society of Interventional Oncology (SIO) invites you to participate in its reimagined master class: the NEXT Summit: Novel Explorations in Combination Therapies.  This two-day event, hosted in partnership with the International Liver Cancer Association (ILCA) and featuring a dedicated session presented in partnership with the Society for Immunotherapy of Cancer (SITC), will  provide a unique opportunity to convene and debate with leading experts the role of y90 and other liver interventions and discuss what’s NEXT in combination therapy. The course will cover both glass and resin y90 data and delivery with lectures from expert faculty, in-depth discussions, and networking with industry partners.

 

Supported by AstraZeneca, Boston Scientific, Eisai, and Sirtex.